Class IIReported 2025-05-07

Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000 bottles, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-450-17

Recalled by ACCORD HEALTHCARE, INC.

Reason for Recall

Subpotent

Recall Number

D-0396-2025

Classification

Class II

Status

Ongoing

Category

drug

Initiated

2025-04-10

Reported

2025-05-07

Distribution

Nationwide US.

Code Info

Lot # D2300044, Exp Date: 12/2025

Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.